← Back to Search

Medication Adherence for Epilepsy

N/A
Recruiting
Led By Ramon Edmundo D Bautista, MD
Research Sponsored by University of Florida
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up to be administered at baseline (upon subject screening), pre-intervention (with 2 weeks prior to intervention), post-intervention (between 6 weeks to 3 months post-intervention), and delayed post-intervention (within 4&1/2 to 6 months post-intervention)
Awards & highlights

Study Summary

This trial is testing different ways to help people with epilepsy manage their condition better. The hope is that this will lead to patients having fewer seizures.

Eligible Conditions
  • Epilepsy

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~to be administered at baseline (upon subject screening), pre-intervention (with 2 weeks prior to intervention), post-intervention (between 6 weeks to 3 months post-intervention), and delayed post-intervention (within 4&1/2 to 6 months post-intervention)
This trial's timeline: 3 weeks for screening, Varies for treatment, and to be administered at baseline (upon subject screening), pre-intervention (with 2 weeks prior to intervention), post-intervention (between 6 weeks to 3 months post-intervention), and delayed post-intervention (within 4&1/2 to 6 months post-intervention) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Changes in Quality of Life in Epilepsy-10 scores

Trial Design

1Treatment groups
Experimental Treatment
Group I: Epilepsy PatientsExperimental Treatment4 Interventions
The group will receive the module (a 1-2 hour course on either medication adherence, seizure documentation, memory improvement or stress management) right after a baseline assessment. A post assessment and delayed post assessment will be conducted after the module is administered.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Medication Adherence
2019
N/A
~100
Stress Management
2011
N/A
~2820

Find a Location

Who is running the clinical trial?

University of FloridaLead Sponsor
1,349 Previous Clinical Trials
719,332 Total Patients Enrolled
5 Trials studying Epilepsy
496 Patients Enrolled for Epilepsy
Dupont Fund, Jesse BallUNKNOWN
Florida Blue FoundationUNKNOWN
~82 spots leftby Jun 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top